vs

Side-by-side financial comparison of AMERISAFE INC (AMSF) and Cardlytics, Inc. (CDLX). Click either name above to swap in a different company.

AMERISAFE INC is the larger business by last-quarter revenue ($80.1M vs $50.9M, roughly 1.6× Cardlytics, Inc.). On growth, AMERISAFE INC posted the faster year-over-year revenue change (10.3% vs -25.5%). Over the past eight quarters, AMERISAFE INC's revenue compounded faster (2.8% CAGR vs -9.6%).

AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.

Cardlytics is a leading purchase intelligence and advertising platform that partners with major banks to analyze anonymized consumer transaction data. It delivers targeted, performance-driven ad campaigns for consumer brands, retailers and service providers, helping advertisers reach audiences based on real purchase behavior, with core operations across North America and the United Kingdom.

AMSF vs CDLX — Head-to-Head

Bigger by revenue
AMSF
AMSF
1.6× larger
AMSF
$80.1M
$50.9M
CDLX
Growing faster (revenue YoY)
AMSF
AMSF
+35.8% gap
AMSF
10.3%
-25.5%
CDLX
Faster 2-yr revenue CAGR
AMSF
AMSF
Annualised
AMSF
2.8%
-9.6%
CDLX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMSF
AMSF
CDLX
CDLX
Revenue
$80.1M
$50.9M
Net Profit
$8.1M
Gross Margin
Operating Margin
-12.0%
Net Margin
10.2%
Revenue YoY
10.3%
-25.5%
Net Profit YoY
-9.0%
EPS (diluted)
$0.43
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMSF
AMSF
CDLX
CDLX
Q1 26
$80.1M
Q4 25
$81.6M
$50.9M
Q3 25
$82.0M
$47.0M
Q2 25
$81.1M
$58.0M
Q1 25
$72.6M
$56.4M
Q4 24
$74.0M
$68.3M
Q3 24
$78.7M
$61.1M
Q2 24
$75.8M
$64.0M
Net Profit
AMSF
AMSF
CDLX
CDLX
Q1 26
$8.1M
Q4 25
$10.4M
Q3 25
$13.8M
$-72.7M
Q2 25
$14.0M
$-9.3M
Q1 25
$8.9M
$-13.3M
Q4 24
$13.2M
Q3 24
$14.3M
$-145.2M
Q2 24
$11.0M
$-4.3M
Operating Margin
AMSF
AMSF
CDLX
CDLX
Q1 26
Q4 25
15.6%
-12.0%
Q3 25
21.3%
-146.6%
Q2 25
21.5%
-22.0%
Q1 25
15.5%
-24.9%
Q4 24
22.7%
-12.2%
Q3 24
22.6%
-243.1%
Q2 24
18.1%
-24.7%
Net Margin
AMSF
AMSF
CDLX
CDLX
Q1 26
10.2%
Q4 25
12.8%
Q3 25
16.9%
-154.7%
Q2 25
17.2%
-16.0%
Q1 25
12.3%
-23.5%
Q4 24
17.8%
Q3 24
18.2%
-237.6%
Q2 24
14.5%
-6.7%
EPS (diluted)
AMSF
AMSF
CDLX
CDLX
Q1 26
$0.43
Q4 25
$0.55
$-0.15
Q3 25
$0.72
$-1.36
Q2 25
$0.73
$-0.18
Q1 25
$0.47
$-0.26
Q4 24
$0.69
$-0.36
Q3 24
$0.75
$-2.90
Q2 24
$0.57
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMSF
AMSF
CDLX
CDLX
Cash + ST InvestmentsLiquidity on hand
$34.2M
$48.7M
Total DebtLower is stronger
$212.6M
Stockholders' EquityBook value
$246.6M
$-6.5M
Total Assets
$285.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMSF
AMSF
CDLX
CDLX
Q1 26
$34.2M
Q4 25
$61.9M
$48.7M
Q3 25
$54.7M
$44.0M
Q2 25
$48.5M
$46.7M
Q1 25
$44.8M
$52.0M
Q4 24
$44.1M
$65.6M
Q3 24
$63.7M
$67.0M
Q2 24
$30.6M
$71.2M
Total Debt
AMSF
AMSF
CDLX
CDLX
Q1 26
Q4 25
$212.6M
Q3 25
$214.6M
Q2 25
$214.3M
Q1 25
$213.9M
Q4 24
$213.6M
Q3 24
$213.2M
Q2 24
$212.9M
Stockholders' Equity
AMSF
AMSF
CDLX
CDLX
Q1 26
$246.6M
Q4 25
$251.6M
$-6.5M
Q3 25
$274.8M
$-4.7M
Q2 25
$265.6M
$58.7M
Q1 25
$260.8M
$64.1M
Q4 24
$257.3M
$70.0M
Q3 24
$314.4M
$69.7M
Q2 24
$301.0M
$210.0M
Total Assets
AMSF
AMSF
CDLX
CDLX
Q1 26
Q4 25
$1.1B
$285.6M
Q3 25
$1.2B
$292.8M
Q2 25
$1.2B
$361.1M
Q1 25
$1.2B
$369.1M
Q4 24
$1.2B
$392.7M
Q3 24
$1.3B
$399.4M
Q2 24
$1.2B
$534.4M
Debt / Equity
AMSF
AMSF
CDLX
CDLX
Q1 26
Q4 25
Q3 25
Q2 25
3.65×
Q1 25
3.34×
Q4 24
3.05×
Q3 24
3.06×
Q2 24
1.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMSF
AMSF
CDLX
CDLX
Operating Cash FlowLast quarter
$13.0M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMSF
AMSF
CDLX
CDLX
Q1 26
Q4 25
$11.1M
$13.0M
Q3 25
$10.7M
$1.8M
Q2 25
$-8.4M
$1.2M
Q1 25
$-1.8M
$-6.7M
Q4 24
$24.2M
$3.0M
Q3 24
$8.4M
$1.4M
Q2 24
$-2.6M
$4.4M
Free Cash Flow
AMSF
AMSF
CDLX
CDLX
Q1 26
Q4 25
$8.9M
$13.0M
Q3 25
$9.8M
$1.7M
Q2 25
$-9.5M
$903.0K
Q1 25
$-1.8M
$-6.8M
Q4 24
$23.4M
$2.9M
Q3 24
$8.4M
$878.0K
Q2 24
$-2.6M
$4.1M
FCF Margin
AMSF
AMSF
CDLX
CDLX
Q1 26
Q4 25
10.9%
25.5%
Q3 25
11.9%
3.7%
Q2 25
-11.7%
1.6%
Q1 25
-2.5%
-12.1%
Q4 24
31.5%
4.2%
Q3 24
10.7%
1.4%
Q2 24
-3.5%
6.5%
Capex Intensity
AMSF
AMSF
CDLX
CDLX
Q1 26
Q4 25
2.6%
0.0%
Q3 25
1.1%
0.0%
Q2 25
1.3%
0.6%
Q1 25
0.0%
0.2%
Q4 24
1.1%
0.2%
Q3 24
0.0%
0.8%
Q2 24
0.1%
0.4%
Cash Conversion
AMSF
AMSF
CDLX
CDLX
Q1 26
Q4 25
1.06×
Q3 25
0.77×
Q2 25
-0.61×
Q1 25
-0.20×
Q4 24
1.83×
Q3 24
0.59×
Q2 24
-0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons